Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genome-wide Association Study of Susceptibility to Rheumatic Heart Disease in Fiji and New Caledonia

NCT02188862 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT02188862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02188862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genome-wide Association Study of Susceptibility to Rheumatic Heart Disease in Fiji and New Caledonia
Lead sponsor
University of Oxford
Phase
Observational
Overall status
Completed
Start date
September 30, 2012
Completion date
December 31, 2013
Enrollment
2,372 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

mitral stenosis, rheumatic heart disease